Cross-agency comparison: 🇪🇺 EMA leads with 49 documents in 90 days

FDA vs EMA vs MHRA vs Health Canada — who's most active?

This cross-agency pattern suggests the EMA is currently the most active and likely the most demanding environment for sponsors to monitor, with Health Canada and the FDA also showing steady output and the MHRA somewhat lower but still material. Pharmaceutical companies should consider that a Europe-first or Europe-heavy filing strategy may require the most frequent regulatory intelligence updates, while global programs may need extra regulatory bandwidth to reconcile differing expectations across regions rather than assuming harmonization.